Data and Insight
Protagen is pleased to share just some of its data and expert insights generated by its precision diagnostics work, which is helping to answer key industry questions to advance the fields of immuno-oncology and autoimmune disease.
At Protagen, helping to accelerate the fields of immuno-oncology and autoimmune disease is our passion, and we try to ensure that the wider scientific community can stay up-to-date with our latest developments by publishing articles, presenting at conferences and even creating eBooks and animations!
We have published peer-reviewed scientific papers which have helped the field gain a better understanding of the underlying principles of some of the world’s most devastating diseases; have authored opinion pieces sharing our immuno-oncology expertise and challenging the field to adopt strategies that can overcome the limitations of immunotherapy; and have even created an animation that demonstrates how understanding the immune system’s delicate balance is key to developing more effective and safer therapies.
Scroll down to find out more:
Protagen’s Dr Peter Schulz-Knappe and Dr Georg Lautscham discuss why carefully monitoring the balance between immune repression and stimulation during cancer immunotherapy will lead to the development of more successful treatments, and suggest why autoantibodies are already showing great promise as powerful tools in this process.
Here you can see some of Protagen’s most recent conference presentations and posters, where the company’s latest advancements in disease research have been shared with delegates from around the world.
Here you will find a number of our visual resources that help explain some of the disease areas we work in, and the challenges we are overcoming. From animations to whitepapers and eBooks, see below for a number of downloadable resources.
Get in touch
Improving the treatment of cancer and autoimmune disease is our passion, and we always welcome the chance to discuss these topics with current and prospective customers, patients and clinicians alike.